Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_assertion type Assertion NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_head.
- NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_assertion description "[Methotrexate and 6-mercaptopurine, important components of acute lymphoblastic leukemia treatment, are substrates for multidrug resistance-associated protein MRP4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_provenance.
- NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_assertion evidence source_evidence_literature NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_provenance.
- NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_assertion SIO_000772 19515727 NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_provenance.
- NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_assertion wasDerivedFrom gad-20150221 NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_provenance.
- NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_assertion wasGeneratedBy ECO_0000203 NP101590.RALU8iDX2e8lPTma3EFBw1ZtPQKOXyvL_N6V1kFu4MBZw130_provenance.